PTSD Trial, Recruiting NCT03932773 Sponsor: The University of Texas at Dallas Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT03932773
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who served in the military in conflicts that took place after September 11, 2001.
  • People who have been formally diagnosed with PTSD (post-traumatic stress disorder) linked to combat experiences in those post-9/11 conflicts, based on a specific clinical assessment called the CAPS-5.

Who may not be able to join:

  • People who are currently enrolled in another experimental treatment for PTSD or are currently receiving trauma-focused therapy.
  • People whose traumatic experience happened within the last 3 months before the pre-enrollment assessment.
  • People with a history of epilepsy, seizures, or a significant head injury.
  • People with any neurological condition that may raise the risk of having a seizure.
  • People who have or have had a brain tumor.
  • People who have had a moderate to severe problem with alcohol or drug use in the last 3 months, or whose substance use puts them at increased risk or causes significant problems in daily life.
  • People who have had a stroke or have abnormal blood vessels in the brain.
  • People diagnosed with dementia.
  • People diagnosed with Parkinson's disease, Huntington's disease, or multiple sclerosis.
  • People assessed as being at high risk of suicide.
  • People with a lifetime history of a psychotic disorder or bipolar disorder.
  • People who are unable to stop taking a medication that significantly lowers the threshold for seizures.
  • People who are pregnant or currently breastfeeding.
  • People who have metal fragments or metal objects in or near their head that cannot be safely removed.
  • People with a history of severe traumatic brain injury or who are considered at high risk for seizures (confirm with trial site for full details on how this is assessed).
  • People who do not speak English, as the screening forms and tests are only available in English.
  • People with a cardiac pacemaker or any implanted medication pump that could increase the risk from the treatment used in this trial (called rTMS).
  • People with any current medical condition that could make it unsafe to receive TMS treatment (confirm with trial site).
  • People using prescription medications or illegal substances that lower the seizure threshold.
  • People who have previously received rTMS treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John Hart, Jr., MD, The University of Texas at Dallas

Phone: 214-883-3171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas at Dallas
Registry
ClinicalTrials.gov
Start date
1 May 2019
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Treatment group differences in change from baseline to 6-months post-treatment on the Clinician Administered Posttraumatic Stress Disorder Scale for Diagnostic and Statistical Manual of Mental Disorders (5th edition) (CAPS-5) Total Severity Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov